{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:37:19Z","timestamp":1790689039961,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142912","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T09:43:17Z","timestamp":1744105397000},"page":"142912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["MicroRNAs as the critical regulators of bone metastasis during prostate tumor progression"],"prefix":"10.1016","volume":"309","author":[{"given":"Meysam","family":"Moghbeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.142912_bb0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"Ferlay","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10408363.2019.1657061","article-title":"Genetic and molecular determinants of prostate cancer among Iranian patients: an update","volume":"57","author":"Ghayour-Mobarhan","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2018.03.028","article-title":"Update on systemic prostate Cancer therapies: Management of Metastatic Castration-resistant Prostate Cancer in the era of precision oncology","volume":"75","author":"Nuhn","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fonc.2014.00364","article-title":"The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis","volume":"4","author":"Ganguly","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/tox.23048","article-title":"Prostate cancer-secreted CCN3 uses the GSK3beta and beta-catenin pathways to enhance osteogenic factor levels in osteoblasts","volume":"36","author":"Chen","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation","volume":"21","author":"Clines","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2018.08.027","article-title":"TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases","volume":"438","author":"Delliaux","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0050","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1158\/1078-0432.CCR-10-2943","article-title":"Inhibition of prostate cancer osteoblastic progression with VEGF121\/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature","volume":"17","author":"Mohamedali","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41388-019-0977-1","article-title":"Notch3 promotes prostate cancer-induced bone lesion development via MMP-3","volume":"39","author":"Ganguly","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166284","article-title":"Tumor cell-derived exosomes from the prostate Cancer cell line TRAMP-C1 impair osteoclast formation and differentiation","volume":"11","author":"Karlsson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","article-title":"Bone metastasis in prostate cancer: emerging therapeutic strategies","volume":"8","author":"Sturge","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2015","key":"10.1016\/j.ijbiomac.2025.142912_bb0070","first-page":"5","article-title":"Cancer statistics","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0080","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0090","doi-asserted-by":"crossref","first-page":"10115","DOI":"10.3390\/molecules190710115","article-title":"MicroRNAs and bone metastasis: a new challenge","volume":"19","author":"Croset","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40364-022-00382-4","article-title":"MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer","volume":"10","author":"Hamidi","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41021-021-00192-4","article-title":"MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells","volume":"43","author":"Zangouei","year":"2021","journal-title":"Genes Environ"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nbt1392","article-title":"MicroRNAs accurately identify cancer tissue origin","volume":"26","author":"Rosenfeld","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0115","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0120","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","article-title":"MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis","volume":"297","author":"Bloomston","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10735-023-10159-0","article-title":"MicroRNA-495: a therapeutic and diagnostic tumor marker","volume":"54","author":"Maharati","year":"2023","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154672","article-title":"Molecular biology of microRNA-342 during tumor progression and invasion","volume":"248","author":"Taghehchian","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2023.101901","article-title":"Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of LASP1 regulation","volume":"68","author":"Guo","year":"2023","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0145","first-page":"81","article-title":"Downregulation of miR-19a-3p promotes invasion, migration and bone metastasis via activating TGF-beta signaling in prostate cancer","volume":"39","author":"Wa","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/aja.2012.116","article-title":"An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions","volume":"15","author":"Zhang","year":"2013","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005275","article-title":"Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone","volume":"4","author":"Mohammad","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1097-2765(01)00332-X","article-title":"The TGF beta receptor activation process: an inhibitor- to substrate-binding switch","volume":"8","author":"Huse","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0165","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGFbeta in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0170","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/0008-5472.CAN-06-3950","article-title":"Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis","volume":"67","author":"Javelaud","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0180","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1073\/pnas.0506517102","article-title":"Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway","volume":"102","author":"Kang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0190","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90298-8","article-title":"REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons","volume":"80","author":"Chong","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(92)90219-4","article-title":"A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells","volume":"9","author":"Mori","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41419-018-0807-3","article-title":"Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-beta signaling","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/j.gastro.2006.06.016","article-title":"A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer","volume":"131","author":"Spaderna","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0210","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.7150\/thno.36735","article-title":"Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-beta signaling","volume":"9","author":"Dai","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.omtn.2019.01.004","article-title":"miR-582-3p and miR-582-5p suppress prostate Cancer metastasis to bone by repressing TGF-beta signaling","volume":"16","author":"Huang","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0220","first-page":"57","article-title":"Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer","volume":"41","author":"Tang","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0225","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/febs.12902","article-title":"lncRNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI","volume":"281","author":"Zhu","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cellsig.2017.05.017","article-title":"SMAD1\/5 mediates bone morphogenetic protein 2-induced up-regulation of BAMBI expression in human granulosa-lutein cells","volume":"37","author":"Bai","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0235","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12967-023-04132-4","article-title":"Circular RNA EPHA3 suppresses progression and metastasis in prostate cancer through the miR-513a-3p\/BMP2 axis","volume":"21","author":"Feng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0240","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.leu.2402824","article-title":"Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0245","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12967-023-04434-7","article-title":"Long non-coding RNAs as the critical regulators of PI3K\/AKT, TGF-beta, and MAPK signaling pathways during breast tumor progression","volume":"21","author":"Maharati","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12935-024-03357-7","article-title":"PI3K\/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells","volume":"24","author":"Moghbeli","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-018-0813-4","article-title":"Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K\/AKT signaling","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0265","first-page":"3438","article-title":"Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer","volume":"8","author":"Di Lorenzo","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0270","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.bjc.6605376","article-title":"Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth","volume":"101","author":"Traish","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0275","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(03)00047-9","article-title":"EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization","volume":"11","author":"Ferguson","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0280","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.18632\/oncotarget.1994","article-title":"Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance","volume":"5","author":"Siu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0285","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-14-3380","article-title":"EGF receptor promotes prostate Cancer bone metastasis by downregulating miR-1 and activating TWIST1","volume":"75","author":"Chang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0290","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0295","first-page":"248","article-title":"Targeting bone metastatic cancer: role of the mTOR pathway","volume":"2014","author":"Bertoldo","year":"1845","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0305","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0310","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/onc.2014.414","article-title":"Transforming growth factor-beta promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway","volume":"34","author":"Siu","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0315","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jcb.21848","article-title":"Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase","volume":"105","author":"Liu","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040115","article-title":"Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context","volume":"4","author":"Mikels","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0325","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2443.2003.00662.x","article-title":"The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a\/JNK signalling pathway","volume":"8","author":"Oishi","year":"2003","journal-title":"Genes Cells"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0330","doi-asserted-by":"crossref","first-page":"21001","DOI":"10.18632\/oncotarget.15471","article-title":"The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness","volume":"8","author":"Chandhoke","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0335","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1593\/neo.06409","article-title":"Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K\/Akt inactivation","volume":"8","author":"Ogata","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0340","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41419-020-2587-9","article-title":"ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis","volume":"11","author":"Tseng","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0350","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/mmi.13885","article-title":"TbSmee1 regulates hook complex morphology and the rate of flagellar pocket uptake in Trypanosoma brucei","volume":"107","author":"Perry","year":"2018","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0355","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0360","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/carcin\/bgt103","article-title":"CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway","volume":"34","author":"Chen","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0365","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1038\/sj.onc.1210413","article-title":"Ubiquitin-mediated activation of TAK1 and IKK","volume":"26","author":"Adhikari","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0370","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncb0805-758","article-title":"Ubiquitin signalling in the NF-kappaB pathway","volume":"7","author":"Chen","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0375","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-017-0645-7","article-title":"Downregulation of miR-141-3p promotes bone metastasis via activating NF-kappaB signaling in prostate cancer","volume":"36","author":"Huang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0380","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.omtn.2019.09.008","article-title":"miR-204-5p represses bone metastasis via inactivating NF-kappaB signaling in prostate Cancer","volume":"18","author":"Wa","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0385","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.omto.2020.03.024","article-title":"Ectopic expression of miR-532-3p suppresses bone metastasis of prostate Cancer cells via inactivating NF-kappaB signaling","volume":"17","author":"Wa","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0390","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-017-0688-6","article-title":"Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-kappaB signaling pathway","volume":"16","author":"Ren","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60327-469-2_1","article-title":"Evolution of the Wnt pathways","volume":"469","author":"Croce","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-022-00315-8","article-title":"Role of microRNAs in regulation of WNT signaling pathway in urothelial and prostate cancers","volume":"23","author":"Montazer","year":"2022","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0410","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0415","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","article-title":"Wnt\/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis","volume":"8","author":"Day","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0420","first-page":"594","article-title":"MicroRNA-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways, Iran J basic","volume":"26","author":"Nasrpour Navaei","year":"2023","journal-title":"Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0425","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.gendis.2022.06.007","article-title":"Antagonizing exosomal miR-18a-5p derived from prostate cancer cells ameliorates metastasis-induced osteoblastic lesions by targeting Hist1h2bc and activating Wnt\/beta-catenin pathway","volume":"10","author":"Zeng","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100494","article-title":"LINC00482 sponged miR-2467-3p to promote bone metastasis of prostate cancer through activating Wnt\/beta-catenin signaling pathway","volume":"41","author":"Liao","year":"2023","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0435","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/pros.23269","article-title":"Suppression of LIM and SH3 domain protein 1 (LASP1) negatively regulated by androgen receptor delays castration resistant prostate Cancer progression","volume":"77","author":"Dejima","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0440","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/onc.2012.216","article-title":"Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions","volume":"32","author":"Mihlan","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0445","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0450","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1349-7006.2010.01742.x","article-title":"Runx2 in human breast carcinoma: its potential roles in cancer progression","volume":"101","author":"Onodera","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0455","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/bdrc.20043","article-title":"Runx2: a master organizer of gene transcription in developing and maturing osteoblasts","volume":"75","author":"Schroeder","year":"2005","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0460","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10555-006-9032-0","article-title":"Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone","volume":"25","author":"Pratap","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0465","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bone.2010.05.035","article-title":"Metastatic bone disease: role of transcription factors and future targets","volume":"48","author":"Pratap","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0470","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1158\/1078-0432.CCR-08-3157","article-title":"Suppression of androgen-independent prostate cancer cell aggressiveness by FTY720: validating Runx2 as a potential antimetastatic drug screening platform","volume":"15","author":"Chua","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0475","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/onc.2009.389","article-title":"Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions","volume":"29","author":"Akech","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.15","article-title":"MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2","volume":"8","author":"Colden","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0485","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","article-title":"The PLAG1-GDH1 Axis promotes Anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung Cancer","volume":"69","author":"Jin","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0490","first-page":"703","article-title":"PLAG1 silencing promotes cell chemosensitivity in ovarian cancer via the IGF2 signaling pathway","volume":"45","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246202","article-title":"Loss of microRNA-135b enhances bone metastasis in prostate Cancer and predicts aggressiveness in human prostate samples","volume":"13","author":"Olivan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0500","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.gendis.2017.01.003","article-title":"HOXB13 mutations and binding partners in prostate development and cancer: function, clinical significance, and future directions","volume":"4","author":"Brechka","year":"2017","journal-title":"Genes Dis"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0505","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/dvdy.24016","article-title":"Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates","volume":"243","author":"Longobardi","year":"2014","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0510","doi-asserted-by":"crossref","first-page":"2178802","DOI":"10.1080\/15592294.2023.2178802","article-title":"CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3\/miR-421\/MEIS2 axis","volume":"18","author":"Dai","year":"2023","journal-title":"Epigenetics"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0515","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0520","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30599","article-title":"MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells","volume":"10","author":"Tolue Ghasaban","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0530","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154472","article-title":"Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells","volume":"245","author":"Mahmoudian","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0540","first-page":"90","article-title":"Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis","volume":"3","author":"Sethi","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0545","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0550","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","article-title":"Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications","volume":"15","author":"Serrano-Gomez","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0555","article-title":"microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition","volume":"12","author":"Luo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0560","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1158\/0008-5472.CAN-07-1328","article-title":"A new central scaffold for metastasis: parsing HEF1\/Cas-L\/NEDD9","volume":"67","author":"O\u2019Neill","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0565","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/ncb1973","article-title":"Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility","volume":"11","author":"Giampieri","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0570","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/jcb.24502","article-title":"HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145","volume":"114","author":"Guo","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0575","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/ijc.21645","article-title":"Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor","volume":"118","author":"Bonfil","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127230","article-title":"The effect of OSM on MC3T3-E1 osteoblastic cells in simulated microgravity with radiation","volume":"10","author":"Goyden","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0585","first-page":"117","article-title":"Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation, genes","volume":"3","author":"Bolin","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0590","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/jcb.29401","article-title":"miR-181b\/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation","volume":"121","author":"Han","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0595","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ctrv.2014.04.003","article-title":"Recent advances in bone-targeted therapies of metastatic prostate cancer","volume":"40","author":"Deng","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0600","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03032599","article-title":"The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis","volume":"7","author":"John","year":"2001","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0605","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00018-007-7486-z","article-title":"Thrombospondins in cancer","volume":"65","author":"Kazerounian","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0610","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1083\/jcb.140.2.419","article-title":"Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis","volume":"140","author":"Kyriakides","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0615","doi-asserted-by":"crossref","first-page":"15993","DOI":"10.1074\/jbc.271.27.15993","article-title":"Metabolism of thrombospondin 2. Binding and degradation by 3t3 cells and glycosaminoglycan-variant Chinese hamster ovary cells","volume":"271","author":"Chen","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0620","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1044-579X(02)00026-3","article-title":"Matrix-directed regulation of pericellular proteolysis and tumor progression","volume":"12","author":"Hornebeck","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0625","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1074\/jbc.M008925200","article-title":"Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2","volume":"276","author":"Yang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0630","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-017-0390-6","article-title":"Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression","volume":"10","author":"Chen","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0635","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2407-9-8","article-title":"YKL-40 tissue expression and plasma levels in patients with ovarian cancer","volume":"9","author":"Hogdall","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0640","first-page":"568","article-title":"Association of serum YKL-40 level with tumor burden and metastatic stage of prostate cancer","volume":"9","author":"Ozdemir","year":"2012","journal-title":"Urol. J."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0645","first-page":"348","article-title":"Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?","volume":"54","author":"Coskun","year":"2007","journal-title":"Neoplasma"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0650","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2147\/OTT.S288785","article-title":"LncRNA KCNQ1OT1 promotes proliferation, invasion and metastasis of prostate Cancer by regulating miR-211-5p\/CHI3L1 pathway","volume":"14","author":"Hao","year":"2021","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0655","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00394-014-0803-z","article-title":"Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-beta from degradation and induce apoptosis in prostate cancer cells","volume":"54","author":"Singh","year":"2015","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0660","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1074\/jbc.M113.542829","article-title":"Regulation of PSMB5 protein and beta subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy","volume":"289","author":"Vangala","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0665","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5301\/ijbm.5000283","article-title":"PSMB5 is associated with proliferation and drug resistance in triple-negative breast cancer","volume":"33","author":"Wei","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0670","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1873-3468.13624","article-title":"Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5","volume":"594","author":"Fan","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154913","article-title":"MicroRNAs as the critical regulators of tumor angiogenesis in liver cancer","volume":"251","author":"Fanoodi","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0680","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-06-2149","article-title":"An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer","volume":"67","author":"Ying","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0685","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(00)00256-4","article-title":"Role of nitric oxide in carcinogenesis and tumour progression","volume":"2","author":"Lala","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0690","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3892\/ijmm.2015.2355","article-title":"MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase","volume":"36","author":"Fu","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0695","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1188015","article-title":"Evidence for an alternative glycolytic pathway in rapidly proliferating cells","volume":"329","author":"Vander Heiden","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.142912_bb0700","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-021-01891-0","article-title":"Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer","volume":"40","author":"Hu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025034646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025034646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:49:03Z","timestamp":1782902943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025034646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":140,"alternative-id":["S0141813025034646"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142912","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs as the critical regulators of bone metastasis during prostate tumor progression","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142912"}}